In brief
The country has recorded over 6.1 million malaria cases in 2024, signaling a worrying trend exacerbated by drug and insecticide resistance, raising concerns for regional implications.
Malaria infection rates have surged alarmingly in Ethiopia, reversing years of hard-won progress against the disease. As of September 2024, more than 6.1 million cases and over 1,000 fatalities have been documented, starkly contrasting the 4.5 million cases and 469 deaths recorded throughout 2023. Experts are bracing for an even steeper rise as the peak malarial season coincides with the heavy rains from September to December.Researcher Fitsum Tadesse, leading the malaria program at the Armauer Hansen Research Institute in Addis Ababa, reflects a collective despair, stating, “We’re backsliding so fast — we’ve gone back a decade.” This resurgence in malaria is not isolated to Ethiopia alone; it potentially foreshadows similar crises in neighboring countries grappling with similar socio-environmental dynamics.Key factors driving this resurgence include increasing resistance of malaria parasites to long-standing treatments and the growing adaptation of mosquitoes to insecticides used in protective measures, such as bed nets and indoor sprays. This dual resistance complicates both diagnosis and treatment efficacy, raising alarms among health experts about the overall vulnerability of populations in this climate-challenged and conflict-ridden region.
